Ng, Michelle
Bardhi, Olgert
Lai, Krystal
Koo, Eden
Yekkaluri, Sruthi
Bass, Kevin
Bhamra, Guruveer
Danpanichkul, Pojsakorn
Quirk, Lisa
Yang, Ju Dong
Louissaint, Jeremy
Kerr, Thomas A.
Singal, Amit G.
Funding for this research was provided by:
National Cancer Institute
Cancer Prevention and Research Institute of Texas
Article History
Received: 26 September 2025
Accepted: 3 December 2025
First Online: 9 December 2025
Declarations
:
: The study was approved by the institutional review board at UT Southwestern Medical Center. The IRB granted a waiver of informed consent given the retrospective nature of the study. The research was designed and conducted in compliance with Helsinki Declaration.
: Not applicable.
: Amit Singal has served as a consultant or on advisory boards for Genentech, AztraZeneca, Eisai, Exelixis, Bayer, Merck, Elevar, Boston Scientific, Sirtex, FujiFilm Medical Sciences, Exact Sciences, Helio Genomics Roche, Glycotest, Abbott, IMCare, Curve Biosciences, DELFI, Universal Dx. None of the authors have relevant conflicts of interest to declare.
: Amit Singal has served as a consultant or on advisory boards for Genentech, AztraZeneca, Eisai, Exelixis, Bayer, Merck, Elevar, Boston Scientific, Sirtex, FujiFilm Medical Sciences, Exact Sciences, Helio Genomics Roche, Glycotest, Abbott, IMCare, Curve Biosciences, DELFI, Universal Dx. None of the authors have relevant conflicts of interest to declare.